Moderna
MRNA
#1123
Rank
โ‚ฌ18.25 B
Marketcap
46,04ย โ‚ฌ
Share price
-0.66%
Change (1 day)
110.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚ฌ18.25 Billion

As of April 2026 Moderna has a market cap of โ‚ฌ18.25 Billion. This makes Moderna the world's 1123th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ18.25 B75.95%
2025โ‚ฌ10.37 B-30.07%
2024โ‚ฌ14.84 B-56.74%
2023โ‚ฌ34.30 B-46.68%
2022โ‚ฌ64.33 B-29.25%
2021โ‚ฌ90.92 B170.54%
2020โ‚ฌ33.60 B471.97%
2019โ‚ฌ5.87 B33.89%
2018โ‚ฌ4.38 B

End of Day market cap according to different sources

On Apr 20th, 2026 the market cap of Moderna was reported to be:

โ‚ฌ18.38 Billion
by Nasdaq info icon info icon
โ‚ฌ18.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ462.72 B 2,434.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ242.48 B 1,228.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚ฌ236.27 B 1,193.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚ฌ0.47 B-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ2.52 B-86.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.7 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ34.93 B 91.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ8.44 B-53.74%๐Ÿ‡บ๐Ÿ‡ธ USA